Prednisone 40 mg Taper Over Six Weeks
Taper prednisone 40 mg gradually by reducing the dose in small increments (5-10 mg decrements) every 1-2 weeks, monitoring closely for withdrawal symptoms, with the understanding that you may need to slow the taper significantly once you reach lower doses (below 10 mg). 1
Practical Tapering Algorithm
The FDA labeling emphasizes that dosage requirements must be individualized based on disease response and patient tolerance, but provides clear guidance that withdrawal should be gradual rather than abrupt 1. Here's a structured approach:
Weeks 1-2: 40 mg → 30 mg
- Start at 40 mg daily, taken in the morning before 9 AM 1
- Reduce by 10 mg after 1-2 weeks if disease is controlled
- Take with food to minimize gastric irritation 1
Weeks 3-4: 30 mg → 20 mg
- Continue 10 mg decrements every 1-2 weeks
- At these supraphysiologic doses, you're primarily managing the underlying disease, not adrenal suppression 2
Weeks 5-6: 20 mg → 10 mg
- Reduce by 5-10 mg
- Critical zone begins: Glucocorticoid withdrawal syndrome becomes more likely as you approach physiological doses 2
Key Considerations for Safe Tapering
Glucocorticoid Withdrawal Syndrome
Expect withdrawal symptoms in up to 50% of patients, including myalgias, weakness, fatigue, sleep disturbances, and mood changes 2. These symptoms:
- Occur due to abrupt decreases in glucocorticoid exposure causing inflammatory cytokine increases
- Overlap significantly with adrenal insufficiency symptoms
- Are more likely with higher initial doses, longer treatment duration, and presence of Cushingoid features 2
If severe withdrawal symptoms occur: Temporarily increase the dose back to the most recent tolerated level, then resume tapering more slowly 2. The 2024 European Society of Endocrinology/Endocrine Society joint guideline specifically recommends extending the taper duration when withdrawal is problematic 2.
When to Slow Down Further
Once you reach doses below 10 mg (approaching the physiological range of 5-7.5 mg prednisone equivalent), you must taper much more slowly 2. Recent 2026 evidence shows that each 1 mg reduction at physiological doses produces measurable HPA axis recovery, with reductions >2 mg producing larger cortisol increases than 1 mg reductions 3. This means:
- Below 10 mg: Consider 2.5 mg decrements every 2-4 weeks
- Below 5 mg: Consider 1 mg decrements every 2-4 weeks
- Final doses may need to be as small as 1 mg or less before complete cessation 3
Disease-Specific Context Matters
The evidence shows significant variation by condition:
- Acute asthma: No benefit to tapering after 10 days of 40 mg daily—abrupt cessation is safe 4, 5
- Myasthenia gravis: Rapid tapering (earlier and faster decrease) with azathioprine showed better outcomes than slow tapering 6
- Autoimmune hepatitis: Slow tapering (≥3 weeks to get below 20 mg) significantly reduced adverse events compared to rapid tapering 7
- Polymyalgia rheumatica: Slow tapering from low initial doses minimizes relapse risk 8
Without knowing your specific condition, err on the side of slower tapering to minimize withdrawal symptoms and disease flare risk.
Critical Pitfalls to Avoid
Don't test adrenal function while on supraphysiologic doses: At 40 mg, HPA axis suppression is expected and testing is unnecessary 2. Only consider testing once you're tapering below physiological doses (5-7.5 mg) and planning complete discontinuation.
Watch for concomitant nephrotoxic medications: Exposure to proton pump inhibitors or trimethoprim-sulfamethoxazole during tapering can prolong recovery time 9.
Don't assume low morning cortisol means you can't stop: Recent evidence shows 42% of patients who successfully discontinued prednisone had nadir morning cortisol <150 nmol/L, including some <28 nmol/L 3. Physiological dose tapering itself enables HPA axis recovery.
Recognize that six weeks may not be enough: For patients on long-term therapy with Cushingoid features, a truly tolerable taper may require many months 2, 3. The six-week timeframe works for getting from 40 mg to approximately 10 mg, but complete discontinuation often requires longer.
Monitoring Strategy
- Weekly check-ins during the first 2-3 weeks to assess disease control
- Every 1-2 weeks thereafter to monitor for withdrawal symptoms
- Slow the taper immediately if withdrawal symptoms emerge—don't push through them 2
- Consider adding steroid-sparing agents if prolonged therapy is anticipated 8
The FDA labeling is explicit: "constant monitoring is needed in regard to drug dosage" and adjustments should be made based on clinical status, individual drug responsiveness, and stressful situations 1.